San Diego, CA, United States of America

Jackie Le

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jackie Le. Retrieved from https://idiyas.com/inventor/jackie-le

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jackie Le - Innovator in Neurocrine Biosciences

Introduction

Jackie Le is an accomplished inventor based in San Diego, CA. She currently works at Neurocrine Biosciences, Inc., where she contributes to innovative research and development in the field of neuroscience. Although she has not yet been granted any patents, her work is focused on significant advancements in medical treatments.

Latest Patent Applications

Jackie Le has submitted several notable patent applications. One of her latest applications is titled "CRF Receptor Antagonists and Methods of Use." This application involves compounds that antagonize corticotropin-releasing factor (CRF) receptors, particularly CRF receptor 1. These compounds are aimed at treating diseases and disorders such as congenital adrenal hyperplasia (CAH). Another application is "Processes for the Synthesis of Valbenazine." This application relates to processes for creating a specific compound that acts as an inhibitor of vesicular monoamine transporter 2 (VMAT2), which is useful in treating hyperkinetic movement disorders like tardive dyskinesia (TD).

Conclusion

Jackie Le is a promising inventor whose work at Neurocrine Biosciences, Inc. is paving the way for future innovations in medical treatments. Her latest patent applications reflect her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…